Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and cyclosporine

raloxifene hydrochloride has been researched along with cyclosporine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Aikens, C; Eyunni, SVK; Hansberry, TD; Mateeva, N; Nag, A; Ononuju, U; Redda, KK1
Hu, M; Jeong, EJ; Lin, H1
Bao, W; Chen, BA; Chen, J; Ding, JH; Gao, C; Gao, F; Ma, Y; Sheng, HL; Sun, YY; Wang, J; Xu, WL; Zhao, G1
Czock, D; Hartmann, B; Keller, F1

Other Studies

6 other study(ies) available for raloxifene hydrochloride and cyclosporine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.
    Bioorganic & medicinal chemistry letters, 2017, 06-01, Volume: 27, Issue:11

    Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Chalcones; Flavonoids; Humans; Structure-Activity Relationship

2017
Disposition mechanisms of raloxifene in the human intestinal Caco-2 model.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biological Transport; Caco-2 Cells; Cyclosporine; Drug Interactions; Estrogen Antagonists; Estrone; Humans; Intestines; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Propionates; Quinolines; Raloxifene Hydrochloride; Time Factors

2004
[Effect of cyclosporine A, raloxifene and their combination on the reversion of multidrug resistance of K562/A02 line].
    Zhongguo shi yan xue ye xue za zhi, 2006, Volume: 14, Issue:5

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; K562 Cells; Raloxifene Hydrochloride; RNA, Messenger

2006
Mean residence time as estimated from cropped and truncated moments.
    Arzneimittel-Forschung, 2009, Volume: 59, Issue:7

    Topics: Algorithms; Anti-Inflammatory Agents; Area Under Curve; Cyclosporine; Data Interpretation, Statistical; Estrogen Antagonists; Half-Life; Humans; Immunosuppressive Agents; Linear Models; Methylprednisolone; Pharmacokinetics; Raloxifene Hydrochloride

2009